Nyxoah S.A. (NYXH): Company Short-Term Debts

Public company logo of Nyxoah S.A (NYXH)

Nyxoah S.A. (NYXH) creates advanced implants to combat apnea and snoring, benefiting from the lifelong management of its clients. The business relies on growing demand from Western ENT centers, supported by fresh clinical reports. The current individual short-term debt figure is 0.03. The share price history below illustrates the price action amid the expansion of high-tech systems in the US and Europe.

NYXH (Nyxoah) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

Analytical breakdowns for Nyxoah S.A (NYXH)

- stock price and consensus target price:
Stock Price Nyxoah|NYXH - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Nyxoah|NYXH - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share Nyxoah S.A.|NYXH - Book Capitalization|Market Value to Book Value Ratio nyxoah.com|NYXH - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Nyxoah S.A.|NYXH - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Nyxoah S.A.|NYXH - Company Total Debt Obligations|Debt to Book Capitalization Ratio Nyxoah|NYXH - Company Long-Term Indebtedness|Company Short-Term Debt Nyxoah S.A.|Quick Liquidity Indicator nyxoah.com
- net income and valuation multiples indicators:
NYXH - Profit After Payment of Taxes
Fundamental company analysis:NYXH - Nyxoah
Flagship merchandise of Nyxoah S.A

Nyxoah S.A. utilizes external board suppliers for the assembly of neurostimulators, which necessitates precise working capital management. The total amount of short-term liabilities maturing within one year reflects the issuer's current liquidity and solvency. This indicator aggregates all urgent debts, highlighting the risks of funding shortages for operational activities. A reduction in this burden confirms financial stability, yet excessive contraction could limit component procurement. By analyzing the dynamics of the current debt load, an investor assesses the reliability of the company's capital structure.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ZIMV|Company Short-Term Debt AngioDynamics ANGO|Company Short-Term Loans and Borrowings CERS|TKNO: Company Current Liabilities|MGRM - Company Short-Term Debts|sharpstechnology.com (STSS) - Company Short-Term Debt|Company Current Liabilities InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Company Short-Term Debts|Short-Term Debt KORU Medical Systems Inc. KRMD|Company Short-Term Debt Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Company Short-Term Indebtedness|Zentek Ltd. - Company Current Liabilities|Amount of Current Liabilities ELUT (elutia.com)|MLSS - Company Short-Term Debt|Short-Term Debt Volume NEXGEL Inc. NXGL|retractable.com (RVP) - Company Short-Term Debt|Company Short-Term Indebtedness HBIO|Company Current Liabilities FEMY|Short-Term Debt Meihua Medical MHUA|Company Current Liabilities POAI (Predictive Oncology)|callanjmb.com - Company Short-Term Indebtedness|Company Short-Term Debt Atrion Corp ATRI|NeuroMetrix Corporation (NURO) - Short-Term Debt